Heska Corp (HSKA) 54.26 $HSKA Qiagen: Molecular
Post# of 273249
Posted On: 09/27/2016 3:39:37 PM
Heska Corp (HSKA) 54.26 $HSKA
Qiagen: Molecular Diagnostics & Expansion Plans on Track
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:14AM CDT
On Sep 13, 2016, we issued an updated research report on Qiagen NV (QGEN).
HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), QGEN: 27.07 (+0.55), ANIK: 46.29 (+0.47)
Zacks.com featured highlights: Sanderson Farms, Children's Place, Heska, Carbonite and HomeStreet
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 8:30AM CDT
Zacks.com featured highlights: Sanderson Farms, Children's Place, Heska, Carbonite and HomeStreet
HMST: 25.03 (+0.07), CARB: 15.38 (+0.07), HSKA: 54.26 (-0.51), PLCE: 79.11 (unch), SAFM: 94.87 (-0.83)
Endure Market Volatility with These 5 Low Beta Stocks
Zacks Equity Research - Zacks Investment Research - Thu Sep 08, 9:49AM CDT
We develop an idea in this article that investors can use to reap solid returns from less risky stocks if they take into account some other investing parameters.
HMST: 25.03 (+0.07), CARB: 15.38 (+0.07), HSKA: 54.26 (-0.51), PLCE: 79.11 (unch), SAFM: 94.87 (-0.83)
Myriad Genetics Adds Assurex Health, Grows in Neuroscience
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 3:36PM CDT
Myriad Genetics, Inc. (MYGN) recently closed its earlier announced acquisition of Assurex Health.
MYGN: 22.04 (+0.47), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
Masimo Amends Nellcor's Pulse Oximetry Royalty Agreement
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 9:08AM CDT
Masimo (MASI) announced that it has amended its royalty agreement with Nellcor.
MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13
PR Newswire - Tue Sep 06, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at CL King's Best Ideas Conference 2016 on Tuesday, September 13, 2016 at 11:45 a.m. ET.
HSKA: 54.26 (-0.51)
Illumina Keen on Genome Network Growth & Global Expansion
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:23PM CDT
On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).
HSKA: 54.26 (-0.51), ILMN: 179.71 (+1.24), ANIK: 46.29 (+0.47)
Align Technology's Invisalign Dependence: Boon or Curse?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:15PM CDT
Align Technology (ALGN) ended the second-quarter 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
ALGN: 94.17 (+1.08), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), EW: 121.12 (+2.18), ANIK: 46.29 (+0.47)
Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:38AM CDT
Myriad (MYGN) ended fiscal 2016 on a disappointing note, with its fourth-quarter numbers missing the Zacks Consensus Estimate on both fronts.
MYGN: 22.04 (+0.47), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
MEDNAX (MD) Acquires Anesthesiology Practice in Nevada
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:33AM CDT
MEDNAX recently announced the acquisition of a private physician group practice -- Associated Anesthesiologists -- in Reno, Nevada.
BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), MD: 65.05 (+0.04)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 27.59 (+0.40), BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51)
Heska (HSKA) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:56AM CDT
As of late, it has definitely been a great time to be an investor in Heska Corp (HSKA).
HSKA: 54.26 (-0.51)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), BEAT: 18.63 (+0.05)
Arena's (ARNA) Q2 Loss Narrower, Revenues Increase Y/Y
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 6:19AM CDT
Arena (ARNA) continues to work on the advancement of its proprietary pipeline candidates.
HSKA: 54.26 (-0.51), CBM: 45.35 (-0.77), ANIP: 68.15 (+2.79), ARNA: 1.79 (+0.06)
Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 5:44AM CDT
Although Kite's (KITE) Q2 loss was wider-than-expected, investor focus remains primarily on the company's progress with KTE-C19.
HSKA: 54.26 (-0.51), CBM: 45.35 (-0.77), KITE: 59.76 (+4.78), AMGN: 171.19 (-2.34)
Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
PR Newswire - Thu Aug 04, 11:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10, 2016 at 4:30 p.m. ET.
HSKA: 54.26 (-0.51)
Heska Reports Record Second Quarter Results
PR Newswire - Wed Aug 03, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company", a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its second quarter ended June 30, 2016.
HSKA: 54.26 (-0.51)
Webcast Alert: Heska Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Tue Aug 02, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 54.26 (-0.51)
Qiagen: Molecular Diagnostics & Expansion Plans on Track
Zacks Equity Research - Zacks Investment Research - Fri Sep 16, 8:14AM CDT
On Sep 13, 2016, we issued an updated research report on Qiagen NV (QGEN).
HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), QGEN: 27.07 (+0.55), ANIK: 46.29 (+0.47)
Zacks.com featured highlights: Sanderson Farms, Children's Place, Heska, Carbonite and HomeStreet
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 8:30AM CDT
Zacks.com featured highlights: Sanderson Farms, Children's Place, Heska, Carbonite and HomeStreet
HMST: 25.03 (+0.07), CARB: 15.38 (+0.07), HSKA: 54.26 (-0.51), PLCE: 79.11 (unch), SAFM: 94.87 (-0.83)
Endure Market Volatility with These 5 Low Beta Stocks
Zacks Equity Research - Zacks Investment Research - Thu Sep 08, 9:49AM CDT
We develop an idea in this article that investors can use to reap solid returns from less risky stocks if they take into account some other investing parameters.
HMST: 25.03 (+0.07), CARB: 15.38 (+0.07), HSKA: 54.26 (-0.51), PLCE: 79.11 (unch), SAFM: 94.87 (-0.83)
Myriad Genetics Adds Assurex Health, Grows in Neuroscience
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 3:36PM CDT
Myriad Genetics, Inc. (MYGN) recently closed its earlier announced acquisition of Assurex Health.
MYGN: 22.04 (+0.47), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
Masimo Amends Nellcor's Pulse Oximetry Royalty Agreement
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 9:08AM CDT
Masimo (MASI) announced that it has amended its royalty agreement with Nellcor.
MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
Heska to Present at CL King's 14th Annual Best Ideas Conference 2016 on September 13
PR Newswire - Tue Sep 06, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at CL King's Best Ideas Conference 2016 on Tuesday, September 13, 2016 at 11:45 a.m. ET. HSKA: 54.26 (-0.51)
Illumina Keen on Genome Network Growth & Global Expansion
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 2:23PM CDT
On Aug 25, 2016, we issued an updated research report on Illumina Inc. (ILMN).
HSKA: 54.26 (-0.51), ILMN: 179.71 (+1.24), ANIK: 46.29 (+0.47)
Align Technology's Invisalign Dependence: Boon or Curse?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:15PM CDT
Align Technology (ALGN) ended the second-quarter 2016 on a promising note, squarely beating the Zacks Consensus Estimate.
ALGN: 94.17 (+1.08), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
FDA Approves Edwards Lifesciences' Intuity Elite Heart Valve
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 5:12PM CDT
Edwards' (EW) Intuity Elite valve system is used to treat patients suffering from coronary artery disease and are required to undergo aortic valve replacement surgery.
HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), EW: 121.12 (+2.18), ANIK: 46.29 (+0.47)
Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:38AM CDT
Myriad (MYGN) ended fiscal 2016 on a disappointing note, with its fourth-quarter numbers missing the Zacks Consensus Estimate on both fronts.
MYGN: 22.04 (+0.47), HSKA: 54.26 (-0.51), ANIP: 68.15 (+2.79), ANIK: 46.29 (+0.47)
MEDNAX (MD) Acquires Anesthesiology Practice in Nevada
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:33AM CDT
MEDNAX recently announced the acquisition of a private physician group practice -- Associated Anesthesiologists -- in Reno, Nevada.
BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), MD: 65.05 (+0.04)
PharMerica (PMC) Q2 Earnings in Line, Revenues Beat
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 7:16AM CDT
PharMerica reported second-quarter 2016 adjusted earnings of 47 cents per share.
PMC: 27.59 (+0.40), BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51)
Heska (HSKA) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:56AM CDT
As of late, it has definitely been a great time to be an investor in Heska Corp (HSKA).
HSKA: 54.26 (-0.51)
BioTelemetry (BEAT) Q2 Earnings, Revenues Beat; View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:25AM CDT
BioTelemetry Inc. reported strong second-quarter 2016 adjusted earnings of 20 cents per share.
BABY: 39.25 (-0.46), MASI: 59.59 (+0.43), HSKA: 54.26 (-0.51), BEAT: 18.63 (+0.05)
Arena's (ARNA) Q2 Loss Narrower, Revenues Increase Y/Y
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 6:19AM CDT
Arena (ARNA) continues to work on the advancement of its proprietary pipeline candidates.
HSKA: 54.26 (-0.51), CBM: 45.35 (-0.77), ANIP: 68.15 (+2.79), ARNA: 1.79 (+0.06)
Kite Pharma (KITE) Q2 Loss Wider but Focus is on KTE-C19
Arpita Dutt - Zacks Investment Research - Tue Aug 09, 5:44AM CDT
Although Kite's (KITE) Q2 loss was wider-than-expected, investor focus remains primarily on the company's progress with KTE-C19.
HSKA: 54.26 (-0.51), CBM: 45.35 (-0.77), KITE: 59.76 (+4.78), AMGN: 171.19 (-2.34)
Heska to Present at Canaccord Genuity 36th Annual Growth Conference on August 10, 2016
PR Newswire - Thu Aug 04, 11:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today announced Kevin Wilson, Chief Executive Officer and President, will present at the Canaccord Genuity 36th Annual Growth Conference on Wednesday, August 10, 2016 at 4:30 p.m. ET. HSKA: 54.26 (-0.51)
Heska Reports Record Second Quarter Results
PR Newswire - Wed Aug 03, 8:00AM CDT
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"
, a provider of advanced veterinary diagnostic and specialty products, today reported financial results for its second quarter ended June 30, 2016. HSKA: 54.26 (-0.51)
Webcast Alert: Heska Announces Second Quarter 2016 Earnings Conference Call Webcast
PR Newswire - Tue Aug 02, 8:00AM CDT
Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
HSKA: 54.26 (-0.51)
(0)
(0)Scroll down for more posts ▼